Shalman Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.74 M
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.48 Cr
- Satisfied Charges ₹ 3.97 Cr
- Revenue Growth 29.94%
- Profit Growth 15.91%
- Ebitda 178.50%
- Net Worth 12.59%
- Total Assets 16.66%
About Shalman Pharmaceuticals
Shalman Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 June 1994 and has a history of 30 years and seven months. Its registered office is in Baroda, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.74 M.
The company currently has active open charges totaling ₹3.48 Cr. The company has closed loans amounting to ₹3.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumit Kapasi, Manojkumar Kapasi, and Siddharth Kapasi serve as directors at the Company.
Company Details
-
LocationBaroda, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1994PTC022380
-
Company No.
022380
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jun 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Shalman Pharmaceuticals Private Limited offer?
Shalman Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Mineral Supplement, Multivitamin Tablets & Capsules, Digestive System Drugs & Medicines, Digestive Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Pain Reliever Gel.
Who are the key members and board of directors at Shalman Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Kapasi
|
Managing Director | 29-Jun-1994 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sumit Kapasi
|
Director | 09-Jun-2006 | Current |
|
Siddharth Kapasi
|
Director | 20-May-2008 | Current |
Financial Performance of Shalman Pharmaceuticals.
Shalman Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.94% increase. The company also saw a substantial improvement in profitability, with a 15.91% increase in profit. The company's net worth Soared by an impressive increase of 12.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shalman Pharmaceuticals?
In 2021, Shalman Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹34.85 M
₹39.72 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2022 | Hdfc Bank Limited | ₹0.96 M | Open |
| 24 Jan 2022 | Hdfc Bank Limited | ₹1.59 M | Open |
| 10 Jul 2015 | Hdfc Bank Limited | ₹3.23 Cr | Open |
| 19 Sep 2008 | State Bank Of India | ₹1.31 Cr | Satisfied |
| 30 Sep 2005 | State Bank Of India | ₹1.31 Cr | Satisfied |
How Many Employees Work at Shalman Pharmaceuticals?
Shalman Pharmaceuticals has a workforce of 33 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shalman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shalman Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
